Norman James Lacayo, MD is a Pediatrician - Pediatric Hematology-Oncology, Pediatrician - General practicing in Palo Alto, CA
He has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| University of Ca, San Francisco, School of Medicine, San Francisco Ca | Other Degree | 1989 | |
| University of California | Medical Degree | 1989 |
| Institution | Focus | Year |
|---|---|---|
| Residency - Stanford University Hospital, Pediatric Hematology-Oncology; University Ca Sf Medical Center, Pediatrics | Not Specified |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | BRITISH JOURL OF HAEMATOLOGY | Development and validation of a single-cell network profiling assay | 2013 |
| Other Publication | LEUKEMIA | Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome | 2013 |
| Other Publication | PLOS ONE | AKT Sigling as a Novel Factor Associated with In Vitro Resistance of Human AML to Gemtuzumab | 2013 |
| Other Publication | BLOOD | Massive evolution of the immunoglobulin heavy chain locus | 2012 |
| Other Publication | LEUKEMIA RESEARCH | Assessing sigling pathways associated with in vitro resistance to cytotoxic agents in AML | 2012 |
| Other Publication | PLOS ONE | Circular Rs Are the Predomint Transcript Isoform from Hundreds of Human Genes in Diverse Cell Types | 2012 |
| Other Publication | JOURL OF NEURO-OPHTHALMOLOGY | Dorsolateral Midbrain MRI Abnormalities | 2011 |
| Other Publication | BRAIN INJURY | A pilot study of an online cognitive rehabilitation program for executive function skills | 2011 |
| Other Publication | LANCET ONCOLOGY | Minimal residual disease-directed therapy for childhood acute myeloid leukaemia | 2010 |
| Other Publication | PEDIATRIC BLOOD & CANCER | Phase I Study of Valspodar | 2010 |
| Other Publication | BLOOD | Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding | 2010 |
| Other Publication | PEDIATRIC BLOOD & CANCER | WT1 Expression at Diagnosis Does Not Predict Survival in Pediatric AML | 2009 |
| Other Publication | PEDIATRIC BLOOD & CANCER | Speeding the Flow Toward Persolized Therapy in Childhood Acute Leukemia | 2009 |
| Other Publication | CANCER GENETICS AND CYTOGENETICS | Molecular inversion probes reveal patterns of 9p21 deletion | 2009 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Genomics of childhood leukemias: The virtue of complexity | 2008 |
| Other Publication | PEDIATRIC AND DEVELOPMENTAL PATHOLOGY | Tissue microarrays from bone marrow aspirates for high | 2008 |
| Other Publication | DM DISEASE-A-MONTH | Acute leukemia in children | 2008 |
| Other Publication | BLOOD | The incidence and clinical significance of nucleophosmin mutations in childhood AML | 2007 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Differential gene expression patterns and interaction networks in BCR-ABL | 2007 |
| Other Publication | CLINICAL CANCER RESEARCH | CpG island methylator phenotype and childhood leukemia | 2006 |
| Other Publication | LEUKEMIA | Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is | 2006 |
| Other Publication | BLOOD | Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission | 2006 |
| Other Publication | Lacayo, N., Meshinchi, S., Raimondi, S., Saraiya, C., O'Brien, M., Yu, | Gene expression profiling and FLT3 status correlate with outcome in de novo acute myeloid leukemia | 2005 |
| Other Publication | BLOOD | Gene expression profiles at diagnosis | 2004 |
| Other Publication | Jourl of experimental therapeutics & oncology | Modulation of resistance to idarubicin by the cyclosporin PSC 833 | 2003 |
| Other Publication | GENES CHROMOSOMES & CANCER | Preferential expression of a mutant allele of the amplified MDR1 | 2002 |
| Other Publication | LEUKEMIA | Pharmacokinetic interactions of cyclosporine with etoposide | 2002 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Mitoxantrone, etoposide | 2000 |
| Other Publication | MOLECULAR PHARMACOLOGY | Loss of cyclosporin | 2000 |
| Other Publication | JOURL OF BIOLOGICAL CHEMISTRY | Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype | 1997 |
Accepts New Patients: Yes
Norman James Lacayo, MD has not yet listed the medications that he commonly prescribes.
